Correlation Between Armata Pharmaceuticals and Amgen

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Armata Pharmaceuticals and Amgen at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Armata Pharmaceuticals and Amgen into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Armata Pharmaceuticals and Amgen Inc, you can compare the effects of market volatilities on Armata Pharmaceuticals and Amgen and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Armata Pharmaceuticals with a short position of Amgen. Check out your portfolio center. Please also check ongoing floating volatility patterns of Armata Pharmaceuticals and Amgen.

Diversification Opportunities for Armata Pharmaceuticals and Amgen

0.64
  Correlation Coefficient

Poor diversification

The 3 months correlation between Armata and Amgen is 0.64. Overlapping area represents the amount of risk that can be diversified away by holding Armata Pharmaceuticals and Amgen Inc in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Amgen Inc and Armata Pharmaceuticals is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Armata Pharmaceuticals are associated (or correlated) with Amgen. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Amgen Inc has no effect on the direction of Armata Pharmaceuticals i.e., Armata Pharmaceuticals and Amgen go up and down completely randomly.

Pair Corralation between Armata Pharmaceuticals and Amgen

Given the investment horizon of 90 days Armata Pharmaceuticals is expected to under-perform the Amgen. In addition to that, Armata Pharmaceuticals is 2.58 times more volatile than Amgen Inc. It trades about -0.04 of its total potential returns per unit of risk. Amgen Inc is currently generating about 0.51 per unit of volatility. If you would invest  25,859  in Amgen Inc on November 6, 2024 and sell it today you would earn a total of  3,028  from holding Amgen Inc or generate 11.71% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Together 
StrengthSignificant
Accuracy100.0%
ValuesDaily Returns

Armata Pharmaceuticals  vs.  Amgen Inc

 Performance 
       Timeline  
Armata Pharmaceuticals 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Armata Pharmaceuticals has generated negative risk-adjusted returns adding no value to investors with long positions. Even with relatively invariable primary indicators, Armata Pharmaceuticals is not utilizing all of its potentials. The latest stock price agitation, may contribute to short-term losses for the retail investors.
Amgen Inc 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Amgen Inc has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of latest conflicting performance, the Stock's technical and fundamental indicators remain healthy and the recent disarray on Wall Street may also be a sign of long period gains for the firm investors.

Armata Pharmaceuticals and Amgen Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Armata Pharmaceuticals and Amgen

The main advantage of trading using opposite Armata Pharmaceuticals and Amgen positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Armata Pharmaceuticals position performs unexpectedly, Amgen can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Amgen will offset losses from the drop in Amgen's long position.
The idea behind Armata Pharmaceuticals and Amgen Inc pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Optimization module to compute new portfolio that will generate highest expected return given your specified tolerance for risk.

Other Complementary Tools

Equity Valuation
Check real value of public entities based on technical and fundamental data
Odds Of Bankruptcy
Get analysis of equity chance of financial distress in the next 2 years
Premium Stories
Follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope
Portfolio Volatility
Check portfolio volatility and analyze historical return density to properly model market risk
Risk-Return Analysis
View associations between returns expected from investment and the risk you assume